Evidence map›Paper›PMID 33013215›Full record

ArticleJournal of the Medical Library Association : JMLA2020

Evaluation of drug information resources for interactions between therapeutic drugs and drugs of abuse.

Robert D Beckett, Jennifer R Martin, Curtis D Stump, Megan A Dyer

Open access · diamondAbstract read
In one paragraph

Article in Journal of the Medical Library Association : JMLA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Tertiary drug information sources for treatment and prevention of COVID-19.Journal of the Medical Library Association : JMLA · 2023
    Article
  2. Off-label use information in electronic drug information resources.Journal of the Medical Library Association : JMLA · 2022
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Robert D Beckettrdbeckett@manchester.edu, Drug Information Center, Manchester University, Fort Wayne, IN.
Jennifer R Martinjenmartin@arizona.edu, Health Sciences Library, University of Arizona, Tucson, AZ.
Curtis D StumpCDStump2018@manchester.edu, Pharmacy Program, Manchester University, Fort Wayne, IN.
Megan A DyerMADyer2018@manchester.edu, Pharmacy Program, Manchester University, Fort Wayne, IN.
Manchester University · USUniversity of Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe study evaluated point-of-care resources for scope, completeness, and consistency of information describing interactions between therapeutic drugs and drugs of abuse (DoA).

methodsA cross-sectional evaluation study was conducted focusing on seven resources: Clinical Pharmacology, Facts & Comparisons eAnswers, Lexicomp Online, Micromedex,

resultsFollowing review by subject matter experts, the final sample contained 159 interactions. Scope scores ranged from 0.6% (

conclusionsAlthough coverage of drug-DoA interactions was low and content was often inconsistent among resources, the provided information was generally complete.

Indexed as

Drug Information ServicesDrug InteractionsCross-Sectional StudiesDatabases, FactualHumansPoint-of-Care Systems

Identifiers

PMID33013215
PMCPMC7524612
OpenAlexW3090557154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.